A strong start to Q1 earnings season and optimism that the U.S. and China will avoid a full-blown trade war has helped stocks rebound from early-April volatility over the past week and a half, renewing investor confidence around the world.
Fresh bullishness over the past few trading periods has inspired positive trading in several key global markets. But interestingly enough, a number of optimistic headlines in the budding marijuana industry has led to an even stronger recovery in this popular investing area.
Canadian marijuana stocks witnessed a massive selloff at the beginning of the month after industry bellwether Canopy Growth Corp. failed to defend its 50-day moving average. These trendy companies are followed by active traders with formulaic strategies, so technical events like this can cause plenty of movement.
But investors who take this market seriously understand that there are a variety of diverse options to focus on. With this in mind, let’s take a closer look at how a few popular stocks with exposure to the marijuana industry have performed over the past few weeks.
Best Canadian Stocks To Invest In 2018: Sensata Technologies Holding N.V.(ST)
- [By Ethan Ryder]
News coverage about Sensata Technologies (NYSE:ST) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Sensata Technologies earned a news sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the scientific and technical instruments company an impact score of 47.3141406855551 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Sensata Technologies (ST)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin] Companies Reporting Before The Bell
United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
PACCAR Inc (NASDAQ: PCAR) is projected to
Best Canadian Stocks To Invest In 2018: Wells Fargo & Company(WFC)
- [By ]
2. Low Debt Levels
By looking through his previous success stories like Coca-Cola (NYSE: KO), American Express (NYSE: AXP), and Wells Fargo (NYSE: WFC), it is clear that Buffett carefully examines a company’s balance sheet, and prefers to invest in those with relatively modest debt burdens.
- [By ]
Citigroup Inc. (C) , a rival Wall Street bank, said in a separate report Friday that first-quarter profit jumped 13%, also fueled by growth in trading revenue. Meanwhile, San Francisco-based Wells Fargo & Co. (WFC) , struggling to recover from a series of regulatory penalties over allegedly aggressive sales practices, posted a 5.5% profit increase on a preliminary basis, noting that legal costs might have to be revised higher pending discussions with regulators over as much as $1 billion of new penalties related to auto insurance and mortgage-related violations. Bank of America Corp. (BAC) , Goldman Sachs Group Inc. (GS) and Morgan Stanley (MS) are all scheduled to post results next week.
- [By SEEKINGALPHA.COM]
The US financial sector has been on a solid run of late. Over the last 12 months the S&P 500 Financials Sector has returned 18.9% relative to the S&P 500 Index of 17.9%. Many analysts have formed the view that with the potential for higher market interest rates, this sector has a long runway ahead. So with this in mind I thought that it would be a good time to update my estimates of the intrinsic value of the 3 major diversified banks. Over a series of 4 articles I will value JPMorgan (NYSE: JPM), Wells Fargo (NYSE: WFC) and Bank of America (NYSE: BAC). In this first article I will set the scene by reviewing the performance of the 3 banks over the last 10 years and compare their current performance to the Sector.
- [By Garrett Baldwin]
The price of Bitcoin faced more pressure over the weekend. The downturn came on news that several major banks have banned the purchasing of Bitcoin with credit cards. Bank of America Corp. (NYSE: BAC), JPMorgan Chase & Co. (NYSE: JPM), and Citigroup Inc. (NYSE: C) have all banned cryptocurrency purchases since Friday. This means that the top five credit card issuers have now halted the practice. Bitcoin sat at $7,773 this morning.
Janet Yellen is officially out of the Federal Reserve and will be heading to the Brookings Institution. Today, Jerome Powell will begin his first term at the helm of the U.S. central bank. Powell takes over at an interesting time for the U.S. economy. The central bank is expected to raise interest rates three times in 2017. In addition, Powell must manage a $4.5 trillion balance sheet that the Fed built up in the wake of last decade’s financial crisis.
Gold prices saw a slight gain in pre-market hours. But those gains could surge as markets continue to face questions about inflation and a weaker U.S. dollar. Gold prices saw one of their biggest one-day declines in two months on Friday. Investors are looking at this as a solid entry point given price expectations from Money Morning Resource Specialist Peter Krauth. Peter expects that gold prices will reach $1,400 by the end of June and rise to as high as $1,500 by December.
VideoMeet the Trading Expert Who Could Help Make You a Millionaire
Crude oil prices slid in pre-market hours to a one-month low. TheWTI crude oil price todayfell 0.6%. Brent crude dropped 1.1%. Markets are growing increasingly fearful that rising U.S. production could spur an oversupply of the markets.
Four Stocks to Watch Today: WFC, AVGO, QCOM, BMY
Shares of Wells Fargo & Co. (NYSE: WFC) are off more than 8% this morning because the Fed has forced new sanctions on the bank that will limit its growth. The Fed’s consent order will see the bank change four members of its board of directors and
- [By ]
Here’s a lesson Wells Fargo & Co. (WFC) CEO Tim Sloan appears to have learned: Be nice to your customers.
The San-Francisco bank has paid about $2 billion in fines and extra legal costs to resolve allegations that it used overly aggressive sales practices over the past decade, including opening millions of accounts without customers’ knowledge and charging auto borrowers for insurance they didn’t need.
Best Canadian Stocks To Invest In 2018: Nu Skin Enterprises Inc.(NUS)
- [By ]
Nu Skin Enterprises (NYSE: NUS) is benefiting from two key trends: its strong presence in Asia where it books 79% of its revenue and leading brand awareness with millennials. The company has increased its dividend every year since 2001, now paying a 2% yield, and maintains a share repurchase program that returns excess cash to shareholders.
Best Canadian Stocks To Invest In 2018: Valeant Pharmaceuticals International Inc(VRX)
- [By ]
In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , American Airlines (AAL) , Align Technology (ALGN) , Procter & Gamble (PG) , United Bankshares (UBSI) , Valeant Pharmaceuticals (VRX) and Dominion Energy (D) .
- [By Dan Caplinger]
The stock market finally hit some resistance on Tuesday, giving up ground and breaking a long streak of consecutive advances for most major benchmarks. Market participants got spooked by a rise in interest rates, with 10-year Treasury yields once again climbing above the 3% mark and leading some to predict even steeper advances in the future. With budget deficits ballooning, higher interest expenses on the national debt could have a dramatic impact on the U.S. economy, especially if it lures investors away from high-flying stocks. Yet even amid the bond-driven downturn, some individual companies saw good news lift their shares. Valeant Pharmaceuticals International (NYSE:VRX), Hollysys Automation Technologies (NASDAQ:HOLI), and Ascena Retail Group (NASDAQ:ASNA) were among the best performers on the day. Here’s why they did so well.
- [By Chris Lange]
Valeant Pharmaceuticals International Inc. (NYSE: VRX) will report its most recent quarterly results on Tuesday as well. The consensus estimates call for $0.60 in EPS and $1.95 billion in revenue. Shares were last seen trading at $18.01, in a 52-week range of $9.70 to $24.43. The consensus price target is $17.03.
- [By Keith Speights]
Valeant Pharmaceuticals (NYSE:VRX) CEO Joe Papa has said for a while that the company is a great turnaround opportunity. But when the drugmaker reported its 2017 fourth-quarter results in February, it was clear that any turnaround wouldn’t happen quickly.